Influence of probiotics on inflammatory bowel disease

Claire W.E.

Independent researcher, Montpellier, France

Abstract

Inflammatory bowel disease (IBD) is one of the crucial immune-mediated inflammatory diseases in which an imbalance occurs within the cellular inflammatory pathways. This article takes a look at what IBD is and the potentials of probiotic use in eradicating or curbing IBD, as well as its particular possible protective influence.

Keywords

probiotics; inflammatory; immune-mediated.

References

1. Kuek, A., Hazleman, B. L., & Östör, A. J. (2007). Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgraduate medical journal, 83(978), 251-260.
2. Klemenak, M., Dolinšek, J., Langerholc, T., Di Gioia, D., & Mičetić-Turk, D. (2015). Administration of Bifidobacterium breve Decreases the Production of TNF-α in Children with Celiac Disease. Digestive diseases and sciences, 60(11), 3386-3392.
3. Lee, S. R., Kim, S., Park, C. E., Lee, J. H., & Lee, D. H. (2019). Effect of Korean medicine as add-on therapy to phototherapy for psoriasis: Two case reports. Medicine, 98(11).
4. Nie, N., Bai, C., Song, S., Zhang, Y., Wang, B., & Li, Z. (2020). Bifidobacterium plays a protective role in TNF-α-induced inflammatory response in Caco-2 cell through NF-κB and p38MAPK pathways. Molecular and cellular biochemistry, 464(1), 83-91.
5. Sales-Campos, H., Soares, S. C., & Oliveira, C. J. F. (2019). An introduction of the role of probiotics in human infections and autoimmune diseases. Critical reviews in microbiology, 45(4), 413-432.
6. Mao, L., Kitani, A., Strober, W., & Fuss, I. J. (2018). The role of NLRP3 and IL-1β in the pathogenesis of inflammatory bowel disease. Frontiers in immunology, 9, 2566.
7. Galipeau, H. J., Caminero, A., Turpin, W., Bermudez-Brito, M., Santiago, A., Libertucci, J., et al. (2021). Novel fecal biomarkers that precede clinical diagnosis of ulcerative colitis. Gastroenterology. https://doi.org/10.1053/j.gastro.2020.12.004
8. Lloyd-Price, J., Arze, C., Ananthakrishnan, A. N., Schirmer, M., Avila-Pacheco, J., Poon, T. W., … & Huttenhower, C. (2019). Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature, 569(7758), 655-662.
9. Gkouskou, K., Deligianni, C., Tsatsanis, C., & Eliopoulos, A. G. (2014). The gut microbiota in mouse models of inflammatory bowel disease. Frontiers in cellular and infection microbiology, 4, 28.
10. Celiberto, L. S., Bedani, R., Rossi, E. A., & Cavallini, D. C. U. (2017). Probiotics: the scientific evidence in the context of inflammatory bowel disease. Critical reviews in food science and nutrition, 57(9), 1759-1768.
11. Nitzan, O., Elias, M., Peretz, A., & Saliba, W. (2016). Role of antibiotics for treatment of inflammatory bowel disease. World journal of gastroenterology, 22(3), 1078.
12. Yan, P. G., & Li, J. N. (2020). Advances in the understanding of the intestinal micro-environment and inflammatory bowel disease. Chinese medical journal, 133(7), 834.
13. Ashaolu, T. J., & Fernández-Tomé, S. (2021). Gut mucosal and adipose tissues as health targets of the immunomodulatory mechanisms of probiotics. Trends in Food Science & Technology, 112, 764–779. doi:10.1016/j.tifs.2021.04.040
14. Wang, Y. N., Meng, X. C., Dong, Y. F., Zhao, X. H., Qian, J. M., Wang, H. Y., & Li, J. N. (2019). Effects of probiotics and prebiotics on intestinal microbiota in mice with acute colitis based on 16S rRNA gene sequencing. Chinese medical journal, 132(15), 1833.
15. Je, I. G., Lee, D. G., Jeong, D. G., Hong, D., Yoon, J. M., Moon, J. S., & Park, S. (2018). The probiotic, ID-JPL934, attenuates dextran sulfate sodium-induced colitis in mice through inhibition of proinflammatory cytokines expression. Journal of medicinal food, 21(9), 858-865.
16. Sood, A., Midha, V., Makharia, G. K., Ahuja, V., Singal, D., Goswami, P., & Tandon, R. K. (2009). The probiotic preparation, VSL# 3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clinical Gastroenterology and Hepatology, 7(11), 1202-1209.
17. Tursi, A., Brandimarte, G., Giorgetti, G. M., Forti, G., Modeo, M. E., & Gigliobianco, A. (2004). Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. Medical science monitor, 10(11), PI126-PI131.
18. Tursi, A., Brandimarte, G., Papa, A., Giglio, A., Elisei, W., Giorgetti, G. M., … & Gasbarrini, A. (2010). Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL# 3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. The American journal of gastroenterology, 105(10), 2218.
19. Fedorak, R. N., Feagan, B. G., Hotte, N., Leddin, D., Dieleman, L. A., Petrunia, D. M., … & Madsen, K. (2015). The probiotic VSL# 3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn’s disease. Clinical Gastroenterology and Hepatology, 13(5), 928-935.
20. Van Gossum, A., Dewit, O., Louis, E., de Hertogh, G., Baert, F., Fontaine, F., … & Franchimont, D. (2007). Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn’s disease after ileo-caecal resection. Inflammatory bowel diseases, 13(2), 135-142.
21. Steed, E., Balda, M. S., & Matter, K. (2010). Dynamics and functions of tight junctions. Trends in cell biology, 20(3), 142-149.
22. Fan, H., Du, J., Liu, X., Zheng, W. W., Zhuang, Z. H., Wang, C. D., & Gao, R. (2019). Effects of pentasa-combined probiotics on the microflora structure and prognosis of patients with inflammatory bowel disease. The Turkish Journal of Gastroenterology, 30(8), 680.
23. Song, H., Wang, W., Shen, B., Jia, H., Hou, Z., Chen, P., & Sun, Y. (2018). Pretreatment with probiotic Bifico ameliorates colitis‐associated cancer in mice: Transcriptome and gut flora profiling. Cancer science, 109(3), 666-677.